213 related articles for article (PubMed ID: 36689700)
1. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review.
Onwusah DO; Ojewole EB; Chimbari MJ
JCO Glob Oncol; 2023 Jan; 9():e2100289. PubMed ID: 36689700
[TBL] [Abstract][Full Text] [Related]
2. Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study.
Onwusah DO; Ojewole EB; Manyangadze T; Chimbari MJ
Patient Prefer Adherence; 2023; 17():2821-2839. PubMed ID: 37953981
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors.
Yang J; Neugut AI; Wright JD; Accordino M; Hershman DL
J Oncol Pract; 2016 Aug; 12(8):e800-9. PubMed ID: 27407167
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
7. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.
Dean LT; George M; Lee KT; Ashing K
Cancer; 2020 Aug; 126(16):3606-3612. PubMed ID: 32438466
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
9. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
[TBL] [Abstract][Full Text] [Related]
10. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.
Cross AJ; Elliott RA; Petrie K; Kuruvilla L; George J
Cochrane Database Syst Rev; 2020 May; 5(5):CD012419. PubMed ID: 32383493
[TBL] [Abstract][Full Text] [Related]
11. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
12. Adherence to targeted oral anticancer medications.
Geynisman DM; Wickersham KE
Discov Med; 2013 Apr; 15(83):231-41. PubMed ID: 23636140
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
14. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of interventions in managing treatment adherence in adult heart transplant patients: a systematic review.
Marcelino CA; Díaz LJ; da Cruz DM
JBI Database System Rev Implement Rep; 2015 Sep; 13(9):279-308. PubMed ID: 26470673
[TBL] [Abstract][Full Text] [Related]
16. The impact of adverse drug reactions on medication adherence and outpatient treatment outcomes in female breast cancer: A review protocol.
Lin ID; Lin KH
J Adv Nurs; 2023 Feb; 79(2):825-831. PubMed ID: 36524324
[TBL] [Abstract][Full Text] [Related]
17. Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
Bright EE; Petrie KJ; Partridge AH; Stanton AL
Breast Cancer Res Treat; 2016 Jul; 158(2):243-51. PubMed ID: 27342455
[TBL] [Abstract][Full Text] [Related]
18. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA
Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596
[TBL] [Abstract][Full Text] [Related]
19. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
[TBL] [Abstract][Full Text] [Related]
20. Health system experiences of breast cancer survivors in urban South Africa.
Lambert M; Mendenhall E; Kim AW; Cubasch H; Joffe M; Norris SA
Womens Health (Lond); 2020; 16():1745506520949419. PubMed ID: 32842917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
